We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Combo Destroys Chemo-resistant Blood Cancer

News   Oct 23, 2018 | Original story from the University of Ottawa

 
Drug Combo Destroys Chemo-resistant Blood Cancer

Leukemia (AML). Credit: National Cancer Institute

 
 
 

RELATED ARTICLES

Novel Drugs Could Improve Long-term Treatment of Poorly Controlled Asthma

News

Preclinical study findings suggest that targeting a promising bitter taste receptor with structurally distinct drugs could help prevent reduced therapeutic effectiveness over time.

READ MORE

When Studying Immune Cells, Environment Matters

News

A new report recommends that looking outside the dish and into living organisms gives an improved understanding of the way immune cells process and use energy.

READ MORE

New Insights Could Change How Concussions Are Treated

News

New research questions the ongoing hypothesis that the blunt force behind a traumatic brain injury (TBI) causes nerve damage, or axonal injury. The findings could influence the treatment of and development of new drugs for TBI.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE